ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Segments

Sumitomo Pharma Co., Ltd. (4506) Segments

Market cap
¥811.7B
P/E ratio
8.8x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce

セグメント売上高

（単位：百万円）2018/032019/032020/032021/032022/032023/032024/032025/03
北米240,791252,542262,295281,493319,790328,467159,037251,814
日本143,325129,287139,675152,497149,915183,624114,65799,838
中国23,44424,74928,60727,83138,29639,397--
海外その他16,46814,28714,78617,23312,17616,752--

セグメント損益

（単位：百万円）2015/032016/032017/03
北米34,71665,15483,288
日本50,57141,53538,307
中国6,2487,9926,742
海外その他8362,4462,803
AI Chat